# ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

> **NCT04883905** · — · RECRUITING · sponsor: **Alnylam Pharmaceuticals** · enrollment: 150 (estimated)

## Conditions studied

- Acute Hepatic Porphyria

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04883905
- **Lead sponsor:** Alnylam Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-26
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04883905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04883905, "ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04883905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*